Dr. Steve Tousignant has accepted a position as the Director of the Swine Business Unit at Newport Laboratories, effective January 31st. For the past five years, he has been employed as a Key Account Veterinarian at Boehringer Ingelheim Animal Health USA Inc. Dr. Tousignant received his DVM from the University of Minnesota in 2011, and his PhD in epidemiology from the University of Minnesota in 2015. Newport Laboratories was acquired by Vaxxinova in September of 2021. Updated contact information for Dr. Tousignant is available at aasv.org/directory. Are you on the move? If so, let us know at aasv@aasv.org.